 |
|
August 28, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
CEO WEEKLY Q&A:
Jason Cole, CEO and Board Member, Zag Bio,
Inc. |
| In
this week’s CEO Q&A, Cole, who lives
with type 1 diabetes himself, discusses
the science behind Zag’s thymus-targeted
platform, what differentiates its approach
from other immune-tolerance strategies in
development, and his outlook for turning
immune tolerance from long-standing
scientific aspiration into real therapies
for patients.
More |
|
|
- Amarin: New REDUCE-IT Legacy Analysis
Presented at European Society of Cardiology
(ESC) Congress 2026 Suggests Persistent
Cardiovascular Benefit Following Icosapent
Ethyl Treatment Cessation in Adherent Patients
More
- Celularity and MuseCell Innovations: U.S.
Manufacturing Collaboration for the Dezawa
MuseCell Platform More
More
- HUTCHMED: NMPA Approval for ATLED
(Fanregratinib) for the Treatment of Patients
With FGFR2-Fusion/Rearrangement Intrahepatic
Cholangiocarcinoma More
- Mission Therapeutics and NeuraLight: Partner
to Bring Precision Brain Function Biomarkers
to a Global Parkinson's Disease Clinical Trial
More
- Neopharma Technologies: Achieves ISO/IEC
42001:2023 AI Management System Certification
for NEOVAULT Global Diagnostics Platform More
- Pfizer and BioNTech: Receive U.S. FDA
Approval for XFG-adapted COVID-19 Vaccine More
- Roivant: FDA Approval of LISRAYA
(brepocitinib) for Adults With
Dermatomyositis; Now Available in the U.S. More
More* More*
More*
|
|
- BMS Splashes Out $173M to Build 2nd
Radiopharmaceutical Plant in Indiana More*
More*
- JATT III Acquisition Corp: Closing of
$69,000,000 Initial Public Offering More
- LSN: Hot Investor Mandates (Updated 8/25) More
- More on Glucotrack Setting 1-for-15 Reverse
Stock Split to Address Nasdaq Requirement More
- Music Beats Cancer: Launches “Thumbs Up for
a Cure” to Support the Next Generation of
Childhood Cancer Treatments
More
- When Revolution Medicines' FDA Win Lifts
Other Boats: SELLAS Life Sciences Stock Surges
More
|
|
- Big4Bio CEO Weekly Q&A: Jason
Cole, CEO and Board Member, Zag Bio, Inc. More
- BioPharmGuy News: 2nd Place Finish, Sugar
Problems, Ghost Roast, Mummy Issues, Fruit
Buds More
- Biotech & Pharma Updates | August 27,
2026 More
- More on Multi-Academic Study Finding No Link
Between Pesticide Exposure and Autism Traits More
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
- Chutes & Ladders—Vivace Revs Up C-Suite
Ahead of Pivotal Push
More
- Daiichi Sankyo to Give Commercial Team a
Makeover; Novo Nordisk’s GPCR Partner Finds
CMO More*
- OPPORTUNITY: Chief Operating Officer, Remote
More
- OPPORTUNITY: Computational Scientist, New
York More
- OPPORTUNITY: Head of
Computational Method Development, Boston
More
- Outlook Therapeutics: Appoints Kevin
Lundquist as Chief Financial Officer as It
Prepares for U.S. Commercial Launch of
LYTENAVA More
- Slone Partners: Fractional
Leadership in Biotech and Life Sciences -
When it Works and Why More
- Slone Partners: Places Farhad Ghavami as
Chief Executive Officer at SeqCenter More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: NYC Life Science Company
Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:NYC,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
